| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/25/2007 | US7273752 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 09/25/2007 | US7273751 Comprises nucleotide sequences associated with expression vector coding endothelial growth factor for use in diagnosis and treatment of tumor angiogenesis, inflammation, diabetic retinopathy, arthritis and psoriasis; wound healing agent |
| 09/25/2007 | US7273744 Heparanase-like polypeptides |
| 09/25/2007 | US7273728 Fermenting an appropriate microorganism using glucose as a carbon source and operating two chromatographic separation steps wherein ion exchange chromatography is followed by hydrophobic interaction chromatography, wherein the diphtheria toxin has a purity of at least 98%. |
| 09/25/2007 | US7273727 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence |
| 09/25/2007 | US7273725 Human and mammalian stem cell-derived neuron survival factors |
| 09/25/2007 | US7273625 Minari extract for preventing the induction and metastasis of cancer by carcinogens contained in cigarette smoke, fermented foods or alcoholic drinks |
| 09/25/2007 | US7273612 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/25/2007 | CA2511753C Phospholipid derivatives |
| 09/25/2007 | CA2415551C Aniline derivatives |
| 09/25/2007 | CA2389766C New indenoindolone derivatives, the procedure for preparing them and the pharmaceutical compounds that contain them |
| 09/25/2007 | CA2306257C 5-azaquinoxaline-based compounds and modulation of serine/threonine protein kinase function |
| 09/25/2007 | CA2294278C Chalcones having antiproliferative activity |
| 09/25/2007 | CA2204160C Treatment of urogenital cancer with boron neutron capture therapy |
| 09/25/2007 | CA2200967C Pharmaceutical compositions |
| 09/25/2007 | CA2173592C Stem cell proliferation factor |
| 09/20/2007 | WO2007106869A1 Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use |
| 09/20/2007 | WO2007106549A2 Method for treating brain cancer |
| 09/20/2007 | WO2007106544A2 Chelating conjugates having a substituted aromatic moiety and derivatives thereof |
| 09/20/2007 | WO2007106391A1 Compounds for modulating cell proliferation, compositions and methods related thereto |
| 09/20/2007 | WO2007106236A2 Pyrrolo-pyridine kinase modulators |
| 09/20/2007 | WO2007105990A1 Inhibitor for differentiation of hematopoietic precursor cells |
| 09/20/2007 | WO2007105989A2 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library |
| 09/20/2007 | WO2007105797A1 Novel human t cell population |
| 09/20/2007 | WO2007105551A1 Novel pyridine derivative having anti-helicobacter pylori activity |
| 09/20/2007 | WO2007105353A1 Plant-derived therapeutic agent for malignant tumor |
| 09/20/2007 | WO2007105058A2 Pyrazole compounds |
| 09/20/2007 | WO2007105045A1 Novel bis-2-difluoro-pyrrolo[2,1-c][1,4]benzodiazepine dimmers |
| 09/20/2007 | WO2007105015A2 DERIVATIVES OF 18ß-GLYCYRRHETINIC ACID |
| 09/20/2007 | WO2007104999A1 Anti-cancer therapy |
| 09/20/2007 | WO2007104944A1 Pyrrolopyrimidine derivatives used as hsp90 inhibitors |
| 09/20/2007 | WO2007104933A1 Chemical compounds |
| 09/20/2007 | WO2007104723A1 Porphyrin derivates and their use as photosensitizers in photodynamic therapy |
| 09/20/2007 | WO2007104714A1 Spiroindolinone derivatives |
| 09/20/2007 | WO2007104664A1 Spiroindolinone derivatives |
| 09/20/2007 | WO2007104558A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors) |
| 09/20/2007 | WO2007104538A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 09/20/2007 | WO2007104254A1 A type of new pyrimidine derivatives having small molecule, preparation methods and uses thereof |
| 09/20/2007 | WO2007104242A1 Compounds capable of inhibiting zinc ion metalloproteinases |
| 09/20/2007 | WO2007104214A1 Camptothecin derivatives and their use |
| 09/20/2007 | WO2007104196A1 Lhrh antagonist possessing low histamine releasing effect |
| 09/20/2007 | WO2007104149A1 Method of preventing or reducing the risk or incidence of cancer using neural thread protein based peptides |
| 09/20/2007 | WO2007104135A1 Bifunctional polyazamacrocyclic chelating agents |
| 09/20/2007 | WO2007084390A3 Histone deacetylase inhibitors |
| 09/20/2007 | WO2007083101A3 Use in an alternative treatment of cancer |
| 09/20/2007 | WO2007082715A3 Anti-cd19 antibody composition and method |
| 09/20/2007 | WO2007075554A3 Combination of igfr inhibitor and anti-cancer agent |
| 09/20/2007 | WO2007071625A3 Cyclic peptides and their use in treating advanced stage neuroblastoma |
| 09/20/2007 | WO2007058823A3 Anti-egfr antibodies |
| 09/20/2007 | WO2007048122A3 Antibody-based therapeutics with enhanced adcc activity |
| 09/20/2007 | WO2007041513A3 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 09/20/2007 | WO2007034479A3 Nanoparticles for targeted delivery of active agents |
| 09/20/2007 | WO2007008671A3 Methods for treating fus1 related disorders |
| 09/20/2007 | WO2007000601A8 Gene regulation |
| 09/20/2007 | WO2006136175A3 Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor |
| 09/20/2007 | WO2006119736A3 Pdz-domain modulators |
| 09/20/2007 | WO2006082098A8 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 09/20/2007 | WO2005019190A3 (4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors |
| 09/20/2007 | WO2002000649A9 Substituted quinazoline derivatives and their use as inhibitors |
| 09/20/2007 | US20070219246 Dihydrobenzothiophenes |
| 09/20/2007 | US20070219233 Substituted Indoles and Their Use as Integrin Antagonists |
| 09/20/2007 | US20070219202 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 09/20/2007 | US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives |
| 09/20/2007 | US20070219194 Phenylalanine derivatives |
| 09/20/2007 | US20070219151 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 09/20/2007 | US20070219148 Small Interfering RNA Specific to Sub-Units $g(a),$g(a)' and $g(b) of the Kinase Protein ck2,and the Applications of the Same |
| 09/20/2007 | US20070219145 Radiosensitizer |
| 09/20/2007 | US20070219128 Medical and health-care uses of pufferfish type I collagen extract and processes for producing said extract |
| 09/20/2007 | US20070219118 Therapeutic methods for nucleic acid delivery vehicles |
| 09/20/2007 | US20070218523 Modified human thymic stromal lymphopoietin |
| 09/20/2007 | US20070218511 Methods for the diagnosis and treatment of lung cancer |
| 09/20/2007 | US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response |
| 09/20/2007 | US20070218070 Methods of modulation of the immune system |
| 09/20/2007 | US20070218066 For clinical screening, diagnosis, prognosis, therapy and prophylaxis of conditions involving the pathology of epithelial cells and particularly those of the alimentary canal |
| 09/20/2007 | US20070218059 Cell Surface Marker |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/20/2007 | US20070218052 Novel lgG3 Antibodies for Stimulating Phagocytosis |
| 09/20/2007 | DE202007007241U1 Krebsprävention an Säugern durch Aktivierung embryonaler Zellen im Verlaufe der ontogenetischen Entwicklung mit Hilfe von Zellwachstumsregulatoren (Auxine) in Kombination mit einem Trägerstoff aus Phospholipiden und Pflanzenölen Cancer prevention in mammals by activation of embryonic cells in the course of ontogenetic development with the help of cell growth regulators (auxins) in combination with a base of phospholipids and vegetable oils |
| 09/20/2007 | DE19882435B4 Verfahren zur Hemmung von Krebszellwachstum mit einem pRb2/p130 exprimierenden Vektor Methods of inhibiting cancer cell growth with a pRb2 / p130 expressing vector |
| 09/20/2007 | CA2646516A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors) |
| 09/20/2007 | CA2646513A1 Antibodies to egfl7 and methods for their use |
| 09/20/2007 | CA2646223A1 Novel heterocyclic nf-kb inhibitors |
| 09/20/2007 | CA2645809A1 Peptidomimetic inhibitors of psma, compounds comprising them, and methods of use |
| 09/20/2007 | CA2645456A1 Photoactive compounds and compositions and uses thereof |
| 09/20/2007 | CA2645350A1 Novel bis-2-difluoro-pyrrolo[2,1-c][1,4]benzodiazepine dimmers |
| 09/20/2007 | CA2645343A1 Pyrrolopyrimidine derivatives used as hsp90 inhibitors |
| 09/20/2007 | CA2645063A1 Porphyrin derivates and their use as photosensitizers in photodynamic therapy |
| 09/20/2007 | CA2645062A1 Spiroindolinone derivatives |
| 09/20/2007 | CA2644758A1 Spiroindolinone derivatives |
| 09/20/2007 | CA2644033A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 09/20/2007 | CA2643239A1 Method of preventing or reducing the risk or incidence of cancer using neural thread protein based peptides |
| 09/20/2007 | CA2643066A1 Pyrazole compounds |
| 09/19/2007 | EP1835027A1 Novel cancer antigen peptide and the use thereof |
| 09/19/2007 | EP1835021A1 Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1834955A1 Porphyrin derivates and their use as photosensitizers in photodynamic therapy |
| 09/19/2007 | EP1834954A1 Thiazoles as NF-kB Inhibitors (proteasome inhibitors) |
| 09/19/2007 | EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 09/19/2007 | EP1834650A1 Cancer vaccine preparation |
| 09/19/2007 | EP1834646A1 Ultrasonic cancer therapy accelerator and cytotoxic agent |